SK284847B6 - Perorálny vodný roztok obsahujúci ako aktívnu zložku 4-amino-5-chlór-2,3-dihydro-N-[1-(3-metoxypropyl)-4-piperidyl]-7- benzofuránkarboxamid a spôsob jeho prípravy - Google Patents

Perorálny vodný roztok obsahujúci ako aktívnu zložku 4-amino-5-chlór-2,3-dihydro-N-[1-(3-metoxypropyl)-4-piperidyl]-7- benzofuránkarboxamid a spôsob jeho prípravy Download PDF

Info

Publication number
SK284847B6
SK284847B6 SK1519-2001A SK15192001A SK284847B6 SK 284847 B6 SK284847 B6 SK 284847B6 SK 15192001 A SK15192001 A SK 15192001A SK 284847 B6 SK284847 B6 SK 284847B6
Authority
SK
Slovakia
Prior art keywords
methoxypropyl
dihydro
chloro
amino
addition salt
Prior art date
Application number
SK1519-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK15192001A3 (sk
Inventor
Proost Eddy Andr� Jos�E De
Original Assignee
Janssen Pharmaceutica N. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N. V. filed Critical Janssen Pharmaceutica N. V.
Publication of SK15192001A3 publication Critical patent/SK15192001A3/sk
Publication of SK284847B6 publication Critical patent/SK284847B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
SK1519-2001A 1999-04-29 2000-04-20 Perorálny vodný roztok obsahujúci ako aktívnu zložku 4-amino-5-chlór-2,3-dihydro-N-[1-(3-metoxypropyl)-4-piperidyl]-7- benzofuránkarboxamid a spôsob jeho prípravy SK284847B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99201335 1999-04-29
PCT/EP2000/003739 WO2000066170A1 (en) 1999-04-29 2000-04-20 Prucalopride oral solution

Publications (2)

Publication Number Publication Date
SK15192001A3 SK15192001A3 (sk) 2002-03-05
SK284847B6 true SK284847B6 (sk) 2006-01-05

Family

ID=8240160

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1519-2001A SK284847B6 (sk) 1999-04-29 2000-04-20 Perorálny vodný roztok obsahujúci ako aktívnu zložku 4-amino-5-chlór-2,3-dihydro-N-[1-(3-metoxypropyl)-4-piperidyl]-7- benzofuránkarboxamid a spôsob jeho prípravy

Country Status (36)

Country Link
US (1) US6413988B1 (ar)
EP (1) EP1176982B1 (ar)
JP (1) JP4773619B2 (ar)
KR (1) KR100669175B1 (ar)
CN (1) CN1165345C (ar)
AR (1) AR023815A1 (ar)
AT (1) ATE254929T1 (ar)
AU (1) AU770073B2 (ar)
BG (1) BG65061B1 (ar)
BR (1) BRPI0010150B8 (ar)
CA (1) CA2371178C (ar)
CZ (1) CZ294070B6 (ar)
DE (1) DE60006799T2 (ar)
DK (1) DK1176982T3 (ar)
EA (1) EA003904B1 (ar)
EE (1) EE05264B1 (ar)
ES (1) ES2211546T3 (ar)
HK (1) HK1045950B (ar)
HR (1) HRP20010764B1 (ar)
HU (1) HU228924B1 (ar)
ID (1) ID30397A (ar)
IL (2) IL146152A0 (ar)
JO (1) JO2181B1 (ar)
MX (1) MXPA01010953A (ar)
MY (1) MY119880A (ar)
NO (1) NO331448B1 (ar)
NZ (1) NZ515119A (ar)
PL (1) PL195674B1 (ar)
PT (1) PT1176982E (ar)
SI (1) SI1176982T1 (ar)
SK (1) SK284847B6 (ar)
TR (1) TR200103121T2 (ar)
TW (1) TW592709B (ar)
UA (1) UA68426C2 (ar)
WO (1) WO2000066170A1 (ar)
ZA (1) ZA200108820B (ar)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050063998A1 (en) * 1999-10-26 2005-03-24 Francois Marc Karel Jozef Oral solution containing galantamine and a sweetening agent
US20040096423A1 (en) * 2000-11-24 2004-05-20 Megens Antonius Adrianus Hendrikus Petrus Use of a triple combination comprising a 5ht3 antagonist, a 5ht4agonist and a laxative for promoting intestinal lavage
CN1330646C (zh) 2002-01-16 2007-08-08 詹森药业有限公司 普卢卡必利－n－氧化物
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
AU2005272598B2 (en) 2004-08-12 2011-11-17 Helsinn Therapeutics (U.S.), Inc. Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
GB201103397D0 (ar) * 2011-02-28 2011-04-13 Shire Movetis N V
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JPH05163154A (ja) * 1991-12-13 1993-06-29 Kanebo Ltd 経口液剤
TW490465B (en) 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
WO2000030640A1 (en) 1998-11-23 2000-06-02 Janssen Pharmaceutica N.V. Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia

Also Published As

Publication number Publication date
CN1165345C (zh) 2004-09-08
CZ294070B6 (cs) 2004-09-15
BRPI0010150B1 (pt) 2015-06-23
EP1176982A1 (en) 2002-02-06
HRP20010764B1 (en) 2011-01-31
EA200101150A1 (ru) 2002-04-25
DE60006799D1 (de) 2004-01-08
CA2371178A1 (en) 2000-11-09
BG106031A (en) 2002-05-31
KR100669175B1 (ko) 2007-01-17
DE60006799T2 (de) 2004-09-23
EE05264B1 (et) 2010-02-15
TW592709B (en) 2004-06-21
HRP20010764A2 (en) 2002-12-31
BRPI0010150B8 (pt) 2021-05-25
CZ20013735A3 (cs) 2002-02-13
NO20014794D0 (no) 2001-10-02
ID30397A (id) 2001-11-29
CN1348386A (zh) 2002-05-08
SI1176982T1 (en) 2004-04-30
JP2002543161A (ja) 2002-12-17
US6413988B1 (en) 2002-07-02
HUP0202324A3 (en) 2003-03-28
EE200100539A (et) 2002-12-16
NO20014794L (no) 2001-10-02
BG65061B1 (bg) 2007-01-31
PL352062A1 (en) 2003-07-28
HUP0202324A2 (hu) 2002-12-28
JP4773619B2 (ja) 2011-09-14
CA2371178C (en) 2008-03-25
NZ515119A (en) 2003-05-30
JO2181B1 (ar) 2003-04-23
DK1176982T3 (da) 2004-03-29
AU4913700A (en) 2000-11-17
MXPA01010953A (es) 2002-05-06
NO331448B1 (no) 2012-01-02
WO2000066170A1 (en) 2000-11-09
HK1045950B (zh) 2005-05-27
PT1176982E (pt) 2004-04-30
SK15192001A3 (sk) 2002-03-05
ATE254929T1 (de) 2003-12-15
TR200103121T2 (tr) 2002-05-21
KR20020004972A (ko) 2002-01-16
UA68426C2 (uk) 2004-08-16
HU228924B1 (en) 2013-06-28
IL146152A0 (en) 2002-07-25
PL195674B1 (pl) 2007-10-31
BR0010150A (pt) 2002-01-15
AR023815A1 (es) 2002-09-04
AU770073B2 (en) 2004-02-12
EP1176982B1 (en) 2003-11-26
MY119880A (en) 2005-07-29
EA003904B1 (ru) 2003-10-30
IL146152A (en) 2006-12-31
HK1045950A1 (en) 2002-12-20
ES2211546T3 (es) 2004-07-16
ZA200108820B (en) 2003-01-27

Similar Documents

Publication Publication Date Title
US20110021786A1 (en) Pharmaceutical Solutions, Process of Preparation and Therapeutic Uses
PL181522B1 (en) Ondansetrone containing oral compositions
US20190209530A1 (en) Powder oral suspension formulations of antibacterial agents
KR101490721B1 (ko) 감칠맛을 가진 디페리프론용 액상 제제
SK284847B6 (sk) Perorálny vodný roztok obsahujúci ako aktívnu zložku 4-amino-5-chlór-2,3-dihydro-N-[1-(3-metoxypropyl)-4-piperidyl]-7- benzofuránkarboxamid a spôsob jeho prípravy
SK42999A3 (en) Aqueous liquid pharmaceutical formulation, process for the preparation and use thereof
WO2000074685A1 (fr) Preparations orales d'etidronate disodique
US20060100271A1 (en) Stabilized aqueous ranitidine compositions
US11564909B2 (en) Methods and compositions for oral pilocarpine liquid
JP2010053048A (ja) 苦味が緩和されたイルベサルタン含有医薬組成物
US20120220630A1 (en) Prucalopride oral solution
GR1009069B (el) Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη

Legal Events

Date Code Title Description
TC4A Change of owner's name

Owner name: SHIRE-MOVETIS N.V., TURNHOUT, BE

Effective date: 20110203

MK4A Expiry of patent

Expiry date: 20200420